About CellsBin
About CellsBin
Built to Reveal the Rare Cells That Shape Human Health
CellsBin is a technology-bio company combining photonics, AI, and translational science to make rare cells visible and turn them into actionable clinical insight.
Our Belief
Clinicians still lack a reliable way to detect and understand the rare cells that can determine disease progression, treatment response, and relapse—limiting their ability to act early and with confidence. We believe Rare-Cell Biology™ is a foundational layer of precision medicine: when low-abundance cells become visible, measurable, and biologically understood, their signals can be translated into actionable clinical decisions that improve how medicine treats patients.
Team
Driven by Purpose. United by Impact.
Dr. Ali Kabiri, PhD
Chief Executive Officer
Nima Sarshar, PhD
Chief Technical Officer
Rebecca MacLeod, PhD
Director of Technology
Julia Peterson
Partnerships Manager
Joel Eisner, PhD
Medical & Scientific Affairs
Joanna Pawlak, PhD
Translational Partnership Lead
Kevin Leary
Strategic Solutions Lead
Dan Buck
Regulatory Affairs
Imman Hosseini
BioChip R&D Lead
Paul Glenn
Innovation Consultant
Maya Moore
Financial Modeling Intern
Mason Williams
Scientific Writing Intern
Build the Future of Rare-Cell Biology™ With Us
We're assembling a team across science, medicine, engineering, and commercial — united by one mission: to make rare cells visible.
Partner With CellsBin
For biopharma, clinical, translational, and technology collaborators advancing rare-cell biology.
Scientific collaboration
Work together on rare-cell biology, translational strategy, and biomarker-driven programs.
Clinical visibility
Generate deeper insight into therapy-cell persistence, tumor-cell dynamics, phenotype, and response.
Platform integration
Leverage CellsBin's technology stack to support research, development, and clinical studies.
Shared impact
Build partnerships that accelerate smarter decisions and better patient outcomes.
Trusted by leading research & clinical partners
